Last reviewed · How we verify
NCT04502121: ValvEx
Preoperative Optimization of Cardiac Valve Patients' Expectations
NA trial testing EXPECT: Preoperative optimization of cardiac valve patient's expectations in Cardiac Valve Disease in 89 participants. Completed in 7 July 2023.
29 November 2022
Quick facts
| Lead sponsor | Philipps University Marburg |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 89 |
| Start date | 17 July 2020 |
| Primary completion | 29 November 2022 |
| Estimated completion | 7 July 2023 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- EXPECT: Preoperative optimization of cardiac valve patient's expectations
Conditions studied
- Cardiac Valve Disease — all drugs for Cardiac Valve Disease →
Sponsor
Philipps University Marburg
Who can join
18 and older, any sex, with Cardiac Valve Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recovery after surgery depends on psychological factors such as preoperative information, expectations and surgery-associated anxiety. Prior studies have shown that even short preoperative psychological interventions can improve postoperative outcomes in heart surgery patients. However, what content works best for which patient group and how long an intervention has to be is still largely unknown. The aims of this study are thus to examine if the developed preoperative psychological intervention (i) reduces preoperative anxiety, (ii) increases positive expectations, and (iii) improves the long-term outcome postoperative recovery. Therefore, a brief intervention has been developed. Heart valve patients who undergo a heart surgery will be randomized into two groups (Control vs. intervention group) after baseline assessment. Following this the intervention group will participate in the psychological intervention (30-40 minutes). To increase patients' positive expectations the intervention will focus on treatment outcome expectations and personal control expectations. Furthermore, patients in the intervention group will have two booster-telephone calls (four and eight weeks after the surgery) to check if their developed plans work out. The control group will receive the standard medical procedure. Both groups will fill out questionnaires again at the evening before the surgery, around one week after the surgery and three months after surgery.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Preoperative optimization of cardiac valve patients' expectations: Study protocol of the randomized controlled ValvEx-trial.
Horn N, Gärtner L, Rastan AJ, Andrási TB, et al · · 2023 · cited 5× · PMID 36937912 · DOI 10.3389/fcvm.2023.1105507 -
Effects of a preoperative psychological expectation-focused intervention in patients undergoing valvular surgery - the randomized controlled ValvEx (valve patients' expectations) study.
Horn N, Gärtner L, Rastan AJ, Andrási TB, et al · · 2025 · cited 1× · PMID 39827935 · DOI 10.1016/j.ahj.2025.01.006
Verify or expand the search:
- PubMed search for NCT04502121
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Valve Disease
Currently open trials in the same condition.
- NCT06247358 — Frailty, Physical Capacity and Lung Function in Postoperative Cardiac Surgery Patients · recruiting
- NCT06336213 — Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients · NA · recruiting
- NCT05002543 — CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting · recruiting
- NCT05506293 — European Multicentre Registry of Percutaneous Paravalvular Leak Closure · recruiting
Other Philipps University Marburg trials
Trials by the same sponsor.
- NCT07498803 — Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome · Phase 2 · not yet recruiting
- NCT07388004 — Group Therapy for Major Depression: Comparing Expectation-Focused and Reward-Focused Psychotherapy Approaches · NA · recruiting
- NCT07166692 — Evaluation of a Retrieval Augmented Large Language Model as a Diagnostic Copilot in Rheumatology · NA · completed
- NCT06865534 — Large Language Models to Aid Gynecological Oncology Treatment · NA · recruiting
- NCT06968897 — Neurological Development In Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04502121 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philipps University Marburg
- Last refreshed: 21 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04502121.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing